Applied Biosystems, now part of Invitrogen, was the first to pioneer a sequencing-by-ligation process, marketing it under the name of SOLiD. The process has some interesting features and is the ...

Geospiza® and GenomeQuest will develop bioinformatics tools that are expected to advance data analysis and management for life scientists utilizing data generated by the SOLiD™ System. Geospiza has ...

Earlier this year, Applied Biosystems used the SOLiD 3 System’s underlying oligonucleotide ligation and detection technology to sequence a human genome for less than $60,000 [in 4 weeks]. Technical ...

Applied Biosystems has announced the worldwide commercial availability of SOLiD, the company’s next-generation DNA sequencing platform, which is expected to simplify the identification ...

Applied Biosystems has announced the launch of the early-access program for its next-generation DNA sequencing system. The company said that it has shipped initial units of its SOLiD™ System to ...

The study in question used second-generation sequencing (with the ABI SOLiD system) to peer inside a single cell isolated from a mouse embryo.

Applied Biosystems expects that the SOLiD™ 3 System will enable scientists to sequence a human genome for approximately $10,000.

Applied Biosystems inked separate agreements with Geospiza® and GenomeQuest to help scientists address next-generation sequencing bioinformatics challenges.

Then Applied Biosystems (ABI) introduced its next-generation sequencing machine, which was quickly followed by instruments from Illumina and Roche 454.

Our aim was to extract maximal sequence from all 15 sampled nodes of the tree in a single run of the Applied Biosystems (ABI) SOLiD platform.

The UCSC Genome Sequencing Center features state-of-the-art equipment, including the GS FLX Titanium Series sequencing platform from 454 Life Sciences and the SOLiD sequencing platform from Applied ...

The GS FLX (TM) system will complement SeqWright's current ABI SOLiD (TM) platform and enable the company to offer a more diverse array of next generation services, including de novo sequencing of ...